how does glp 1 microdosing work GLP-1 is popular, but there's little evidence it works THE PCCA BLOG | Microdosing

As newer incretin therapies continue to emerge, clinicians will likely gain additional tools for addressing diminished response to GLP-1 medications

Still, for now, they continue to capture the attention of patients, providers, and insurers alike

Individual neurological vulnerability

GLP-1R agonists represents a novel class of anti-hyperglycemic agent that improve health and survival of -cells (improvement in postprandial hyperglycemia), suppress glucagon (improvement in fasting hyperglycemia), improve insulin resistance (modest effect) and influence energy intake (augment satiety signal) with minimal, if at all, any side effects (weight neutral and non-hypoglycemic)

What labs or monitoring are required